Literature DB >> 9876947

Hepatocellular carcinoma: significance of HBV vertical transmission.

Y Poovorawan1, R Sripattanawat, A Theamboonlers, V Chongsrisawat, I Nuchprayoon.   

Abstract

In two cases of childhood hepatocellular carcinoma in Thailand, we established vertical transmission of hepatitis B virus infection as the underlying cause. With the first patient, the family history of HBV carriage became evident and a pedigree could be devised which demonstrated the high prevalence among the family members and hence evidence of vertical transmission. In the case of the second patient, we performed PCR and subsequent direct sequencing of HBV DNA isolated from his HBsAg-positive mother's, as well as from his serum, comparing the nucleotide sequences with those of a pregnant woman diagnosed as an asymptomatic HBV carrier, of another asymptomatic HBV carrier and of a reference strain, respectively, all belonging to the same genotype and subtype as the samples tested. Our results clearly indicate the necessity for nation-wide hepatitis B vaccination starting at birth, at least in hyperendemic areas like the Far East, in order to forestall HBV carriage and ensuing cirrhosis and/or HCC by preventing vertical transmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9876947

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  3 in total

1.  Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review.

Authors:  Javier Santiago-Reynoso; Karina Senyase Zamaripa-Martínez; Juan Manuel Dorantes-Loya; Guillermo J Gaytán-Fernández; Evelia Apolinar-Jiménez; Francisco Paz-Gómez; Felipe Farias-Serratos; María Maldonado-Vega
Journal:  Gastrointest Tumors       Date:  2019-05-27

2.  Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.

Authors:  Hitoshi Tajiri; Tomoko Takano; Hideo Tanaka; Kosuke Ushijima; Ayano Inui; Yoko Miyoshi; Keiichi Ozono; Daiki Abukawa; Takeshi Endo; Stephen Brooks; Yasuhito Tanaka
Journal:  Cancer Med       Date:  2016-10-17       Impact factor: 4.452

3.  HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining.

Authors:  Xizhan Xu; Kuanhui Xiang; Mingze Su; Yao Li; Wei Ji; Yutang Li; Hui Zhuang; Tong Li
Journal:  Viruses       Date:  2017-07-27       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.